Vir Biotech Catapults On Its $1.71 Billion Deal With Astellas - Investor's Business Daily
Source:Investor's Business Daily
Vir posted strong results for a prostate cancer treatment and crushed fourth-quarter views.
Vir posted strong results for a prostate cancer treatment and crushed fourth-quarter views.